Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
April 10, 2024 04:05 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
February 21, 2024 11:34 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech
January 24, 2024 14:18 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
Vaccine Adjuvant Market Size Worth USD 1.75 Billion in 2032 | Emergen Research
January 10, 2024 07:48 ET
|
Emergen Research
Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global vaccine adjuvant market size was USD 0.90 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.0% during the forecast period....
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
December 18, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
November 06, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on the potential use of investigational cancer immunotherapy...
Vaccine Adjuvants Global Market Report 2022: Government Initiatives Promoting Vaccination Bolsters Sector
October 07, 2022 08:38 ET
|
Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Vaccine Adjuvants Market Report (2022 to 2027) - Rising Funding for Vaccines and Infectious Disease Research Activities Presents Opportunities
October 04, 2022 08:53 ET
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market by Product (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease...
Outlook on the Vaccine Adjuvants Global Market to 2035 - Industry Trends and Forecasts
June 21, 2022 06:28 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and...
Global Vaccine Adjuvants Market Worth $1.47 Billion by 2026 - Key Players are Adjuvatis, GSK, Croda International, Merck KGaA, and Novavax
December 08, 2021 04:03 ET
|
Research and Markets
Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)" report has been added to ResearchAndMarkets.com's offering. ...